Outlook Therapeutics, Inc.
public$OTLK View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $OTLK
No disclosed congressional trades found in $OTLK.
Insider Trades (Form 4)
GRANTChief Financial Officer
KENYON LAWRENCE A
210,078 shares Jul 23, 2026
GRANTChief Executive Officer
Jahr Robert Charles
100,000 shares Jul 23, 2026
BUYDirector
Sukhtian Ghiath M.
$5,000,0008,539,709 shares Jun 2, 2026
BUYDirector
GMS Ventures & Investments
$5,000,0008,539,709 shares Jun 2, 2026
Key People
Jahr Robert Charles
Chief Executive Officer
BoardInsider
KENYON LAWRENCE A
Chief Financial Officer
BoardInsider
ARCH Venture Partners
Related Person
Flagship Pioneering
Related Person
GMS Ventures & Investments
Director
BoardInsider
Sukhtian Ghiath M
Director
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro